Evidence map›Paper›PMID 28317389›Full record

ArticleCartilage2017

PRP for Degenerative Cartilage Disease: A Systematic Review of Clinical Studies.

Lior Laver, Niv Marom, Lad Dnyanesh, Omer Mei-Dan, João Espregueira-Mendes, Alberto Gobbi

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Cartilage, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04051203 phase1completednot on this mapstarted 2019, after this paper: background citation

Ultrasound Guided Platelet Rich Plasma Injections for Post Traumatic Greater Occipital Neuralgia: A Randomized Controlled Pilot Study

TypeinterventionalSponsorUniversity of CalgaryRan2019 to 2023Enrolled35ConditionsOccipital Neuralgia, HeadacheArmsAutologous Platelet Rich Plasma Injection, Depo-Medrol and lidocaine, Normal Saline
NCT06543368 nacompletednot on this mapstarted 2024, after this paper: background citation

Low-Cost Platelet-Rich Plasma Injection for the Management of Hemarthropathy

TypeinterventionalSponsorUniversity of UtahRan2024 to 2025Enrolled14ConditionsHemarthrosis, HemophiliaArmsIntra articular PRP Injection
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 143 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Spin and reporting bias in the use of platelet-rich plasma for the treatment of knee osteoarthritis.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Infiltration therapy in the context of cartilage surgery.Archives of orthopaedic and trauma surgery · 2024
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Advances with Platelet-Rich Plasma for Bone Healing.Biologics : targets & therapy · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Biotherapeutic Applications of Platelet-Rich Plasma in Regenerative Medicine.Tissue engineering and regenerative medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Lior Laver1 Department of Orthopaedics and Sports Medicine Service, "Meir" Medical Center and Tel-Aviv University Hospital, Kfar-Saba, Israel.
Niv Marom1 Department of Orthopaedics and Sports Medicine Service, "Meir" Medical Center and Tel-Aviv University Hospital, Kfar-Saba, Israel.
Lad Dnyanesh2 O.A.S.I. Bioresearch Foundation Gobbi NPO, Milan, Italy.
Omer Mei-Dan3 Sports Medicine and Hip Preservation Service, Department of Orthopedics, University of Colorado, Aurora, CO, USA.
João Espregueira-Mendes4 Orthopaedics Department of Minho University, Minho, Portugal.
Alberto Gobbi2 O.A.S.I. Bioresearch Foundation Gobbi NPO, Milan, Italy.
OASI Bioresearch Foundation · ITMeir Medical Center · ILTel Aviv University · ILUniversity of Colorado Denver · USUniversity of Minho · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the utilization of platelet-rich plasma (PRP) for degenerative cartilage processes and evaluate whether there is sufficient evidence to better define its potential effects.

designSystematic literature reviews were conducted in PubMed/MEDLINE and Cochrane electronic databases till May 2015, using the keywords "platelet-rich plasma OR PRP OR autologous conditioned plasma OR ACP AND cartilage OR chondrocyte OR chondrogenesis OR osteoarthritis (OA) OR arthritis."

resultsThe final result yielded 29 articles. Twenty-six studies examined PRP administration for knee OA and 3 involved PRP administration for hip OA. The results included 9 prospective randomized controlled trials (RCTs) (8 knee and 1 hip), 4 prospective comparative studies, 14 case series, and 2 retrospective comparative studies. Hyaluronic acid (HA) was used as a control in 11 studies (7 RCTs, 2 prospective comparative studies, and 2 retrospective cohort). Overall, all RCTs reported on improved symptoms compared to baseline scores. Only 2 RCTs-one for knee and one for hip-did not report significant superiority of PRP compared to the control group (HA). Nine out of 11 HA controlled studies showed significant better results in the PRP groups. A trend toward better results for PRP injections in patients with early knee OA and young age was observed; however, lack of uniformity was evident in terms of indications, inclusion criteria, and pathology definitions in the different studies.

conclusionCurrent clinical evidence supports the benefit in PRP treatment for knee and hip OA, proven to temporarily relieve pain and improve function of the involved joint with superior results compared with several alternative treatments. Further research to establish the optimal preparation protocol and characteristics of PRP injections for OA is needed.

Indexed as

cartilagehyaluronic acidinjectionsosteoarthritisplatelet-rich plasmaPRP

Identifiers

PMID28317389
PMCPMC5613892
OpenAlexW2525857977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.